Institution · EB House Austria
Most cited papers from EB House Austria
What are the most cited papers from EB House Austria?
The most cited paper from EB House Austria is "Regeneration of the entire human epidermis using transgenic stem cells" (Tobias Hirsch et al., 2017), with 716 citations. Next come "Human CD4 + CD103 + cutaneous resident memory T cells are found in the circulation of healthy individuals" (266) and "Clinical practice guidelines for laboratory diagnosis of epidermolysis bullosa" (155).
Showing 50 of 59 papers. Every paper with more than 31 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Regeneration of the entire human epidermis using transgenic stem cells Tobias Hirsch et al. · Nature | Nov 2017 | 716 |
| 2 | Human CD4 + CD103 + cutaneous resident memory T cells are found in the circulation of healthy individuals Maria M. Klicznik, Peter A. Morawski, Barbara Höllbacher et al. · Science Immunology | 5 Jul 2019 | 266 |
| 3 | Clinical practice guidelines for laboratory diagnosis of epidermolysis bullosa Cristina Has, L. Liu, Maria C. Bolling et al. · British Journal of Dermatology | 15 May 2019 | 155 |
| 4 | APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa Raymond Jaihyun Cho et al. · Science Translational Medicine | 22 Aug 2018 | 135 |
| 5 | Closure of a Large Chronic Wound through Transplantation of Gene-Corrected Epidermal Stem Cells Johann Wolfgang Bauer, Josef Koller, Eva Maria Murauer et al. · Journal of Investigative Dermatology | 10 Nov 2016 | 125 |
| 6 | Organ-Specific and Memory Treg Cells: Specificity, Development, Function, and Maintenance Iris Karina Gratz, Daniel Campbell · Frontiers in Immunology | 15 Jul 2014 | 122 |
| 7 | COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis Bullosa Stefan Hainzl, Patricia Peking, Thomas Köcher et al. · Molecular Therapy | 13 Jul 2017 | 104 |
| 8 | Epidermolysis bullosa: Advances in research and treatment Christine Maria Prodinger, Julia Reichelt, Johann Wolfgang Bauer et al. · Experimental Dermatology | 29 May 2019 | 94 |
| 9 | Cut and Paste: Efficient Homology-Directed Repair of a Dominant Negative KRT14 Mutation via CRISPR/Cas9 Nickases Thomas Köcher, Patricia Peking, Alfred Klausegger et al. · Molecular Therapy | 24 Aug 2017 | 93 |
| 10 | Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosa Su M. Lwin et al. · JCI Insight | 5 Jun 2019 | 92 |
| 11 | Laminin 332-Dependent YAP Dysregulation Depletes Epidermal Stem Cells in Junctional Epidermolysis Bullosa Laura De Rosa, Alessia Secone Seconetti, Giorgio De Santis et al. · Cell Reports | May 2019 | 91 |
| 12 | Functional Correction of Type VII Collagen Expression in Dystrophic Epidermolysis Bullosa Eva Maria Murauer, Yannick Gache, Iris Karina Gratz et al. · Journal of Investigative Dermatology | 19 Aug 2010 | 90 |
| 13 | Mitochondrial dysfunction: a neglected component of skin diseases René Günther Feichtinger, Wolfgang Sperl, Johann Wolfgang Bauer et al. · Experimental Dermatology | Jul 2014 | 89 |
| 14 | Regulatory T cells in skin mediate immune privilege of the hair follicle stem cell niche Jarish N. Cohen, Victoire Gouirand, Courtney E. Macon et al. · Science Immunology | 5 Jan 2024 | 86 |
| 15 | Clinical trial of ABCB5+ mesenchymal stem cells for recessive dystrophic epidermolysis bullosa Dimitra Kiritsi et al. · JCI Insight | 19 Oct 2021 | 86 |
| 16 | Amlexanox Enhances Premature Termination Codon Read-Through in COL7A1 and Expression of Full Length Type VII Collagen: Potential Therapy for Recessive Dystrophic Epidermolysis Bullosa Velina S. Atanasova, Qiujie Jiang, Marco di Prisco et al. · Journal of Investigative Dermatology | 13 Jun 2017 | 84 |
| 17 | Transcriptome and ultrastructural changes in dystrophic Epidermolysis bullosa resemble skin aging Jenny Breitenbach, Mark Rinnerthaler, Andrea Trost et al. · Aging | 14 Jun 2015 | 84 |
| 18 | Spliceosome-Mediated Trans-Splicing: The Therapeutic Cut and Paste Verena Wally, Eva Maria Murauer, Johann Wolfgang Bauer · Journal of Investigative Dermatology | 12 Apr 2012 | 78 |
| 19 | Diacerein orphan drug development for epidermolysis bullosa simplex: A phase 2/3 randomized, placebo-controlled, double-blind clinical trial Verena Wally, Alain Hovnanian, Juliette Ly et al. · Journal of the American Academy of Dermatology | 2 Feb 2018 | 73 |
| 20 | Thrombospondin-1 Is a Major Activator of TGF-β Signaling in Recessive Dystrophic Epidermolysis Bullosa Fibroblasts Velina S. Atanasova, Rebecca J. Russell, Timothy G. Webster et al. · Journal of Investigative Dermatology | 24 Jan 2019 | 72 |
| 21 | 5′ Trans-Splicing Repair of the PLEC1 Gene Verena Wally, Alfred Klausegger, Ulrich Koller et al. · Journal of Investigative Dermatology | 8 Nov 2007 | 72 |
| 22 | Gentamicin induces LAMB3 nonsense mutation readthrough and restores functional laminin 332 in junctional epidermolysis bullosa Vadim Lincoln, Jon P. Cogan, Yingping Hou et al. · Proceedings of the National Academy of Sciences | 26 Jun 2018 | 70 |
| 23 | Taking the lead – how keratinocytes orchestrate skin T cell immunity Maria M. Klicznik, Antal Balázs Szenes-Nagy, Daniel Campbell et al. · Immunology Letters | 30 Jun 2018 | 65 |
| 24 | Transcriptomic Profiling of Human Effector and Regulatory T Cell Subsets Identifies Predictive Population Signatures Barbara Höllbacher, Thomas Duhen, Samantha Motley et al. · ImmunoHorizons | Oct 2020 | 64 |
| 25 | Topical diacerein for epidermolysis bullosa: a randomized controlled pilot study Verena Wally, Sophie Kitzmueller, Florian B. Lagler et al. · Orphanet Journal of Rare Diseases | 2013 | 63 |
| 26 | K14 mRNA reprogramming for dominant epidermolysis bullosa simplex Verena Wally, Marietta Brunner, Thomas Lettner et al. · Human Molecular Genetics | 22 Sep 2010 | 61 |
| 27 | On- and off-target effects of paired CRISPR-Cas nickase in primary human cells Julia Klermund, Manuel Rhiel, Thomas Köcher et al. · Molecular Therapy | 7 Mar 2024 | 59 |
| 28 | QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical Study Olivier Bornert, Marieke Hogervorst, Pauline Nauroy et al. · Journal of Investigative Dermatology | 15 Sep 2020 | 53 |
| 29 | Impact of low-dose calcipotriol ointment on wound healing, pruritus and pain in patients with dystrophic epidermolysis bullosa: A randomized, double-blind, placebo-controlled trial Christina Guttmann‐Gruber, Josefina Piñón Hofbauer, Birgit Tockner et al. · Orphanet Journal of Rare Diseases | 8 Nov 2021 | 52 |
| 30 | The Pathogenetic Role of IL-1β in Severe Epidermolysis Bullosa Simplex Verena Wally, Thomas Lettner, Patricia Peking et al. · Journal of Investigative Dermatology | 23 Jan 2013 | 51 |
| 31 | Lesion-Induced Accumulation of Platelets Promotes Survival of Adult Neural Stem / Progenitor Cells Ilias Kazanis, Martina Feichtner, Simona Lange et al. · Experimental Neurology | 8 Apr 2015 | 50 |
| 32 | Traceless Targeting and Isolation of Gene-Edited Immortalized Keratinocytes from Epidermolysis Bullosa Simplex Patients Magomet Aushev, Ulrich Koller, Claudio Mussolino et al. · Molecular Therapy — Methods & Clinical Development | 4 Jul 2017 | 49 |
| 33 | Improved Double-Nicking Strategies for COL7A1-Editing by Homologous Recombination Thomas Köcher, Roland N. Wagner, Alfred Klausegger et al. · Molecular Therapy — Nucleic Acids | 20 Sep 2019 | 48 |
| 34 | Reduced Microbial Diversity Is a Feature of Recessive Dystrophic Epidermolysis Bullosa-Involved Skin and Wounds Ignacia Fuentes, Christina Guttmann‐Gruber, Angeline Su Ling Tay et al. · Journal of Investigative Dermatology | 16 May 2018 | 46 |
| 35 | Low-dose calcipotriol can elicit wound closure, anti-microbial, and anti-neoplastic effects in epidermolysis bullosa keratinocytes Christina Guttmann‐Gruber, Birgit Tockner, Cornelia Scharler et al. · Scientific Reports | 3 Sep 2018 | 45 |
| 36 | Gene Editing–Mediated Disruption of Epidermolytic Ichthyosis–Associated KRT10 Alleles Restores Filament Stability in Keratinocytes Oliver Patrick March, Thomas Lettner, Alfred Klausegger et al. · Journal of Investigative Dermatology | 15 Apr 2019 | 44 |
| 37 | A Gene Gun-mediated Nonviral RNA trans-splicing Strategy for Col7a1 Repair Patricia Peking, Ulrich Koller, Stefan Hainzl et al. · Molecular Therapy — Nucleic Acids | 2016 | 44 |
| 38 | Identification of Rigosertib for the Treatment of Recessive Dystrophic Epidermolysis Bullosa–Associated Squamous Cell Carcinoma Velina S. Atanasova et al. · Clinical Cancer Research | 7 Mar 2019 | 41 |
| 39 | 8th European Conference on Rare Diseases & Orphan Products (ECRD 2016) Michael Schlander et al. · Orphanet Journal of Rare Diseases | Nov 2016 | 40 |
| 40 | Construction and validation of an RNA trans-splicing molecule suitable to repair a large number of COL7A1 mutations Birgit Tockner, Thomas Köcher, Stefan Hainzl et al. · Gene Therapy | 19 Jul 2016 | 40 |
| 41 | Targeting proliferation of chronic lymphocytic leukemia (CLL) cells through KCa3.1 blockade Eva Melanie Grössinger, L Weiss, Susanna Zierler et al. · Leukemia | 20 Jan 2014 | 39 |
| 42 | Toward Combined Cell and Gene Therapy for Genodermatoses Laura De Rosa, Maria Carmela Latella, Alessia Secone Seconetti et al. · Cold Spring Harbor Perspectives in Biology | 25 Oct 2019 | 38 |
| 43 | Predictable CRISPR/Cas9-Mediated COL7A1 Reframing for Dystrophic Epidermolysis Bullosa Thomas Köcher, Oliver Patrick March, Johannes Bischof et al. · Journal of Investigative Dermatology | 3 Mar 2020 | 37 |
| 44 | The significance of stress hormones (glucocorticoids, catecholamines) for eruptions and spontaneous remission phases in psoriasis Bea A. Weigl · International Journal of Dermatology | Sep 2000 | 37 |
| 45 | S1 guidelines for the diagnosis and treatment of ichthyoses – update Vinzenz Oji et al. · JDDG Journal der Deutschen Dermatologischen Gesellschaft | Oct 2017 | 36 |
| 46 | RNA ‐based therapies for genodermatoses Olivier Bornert, Patricia Peking, Jeroen Bremer et al. · Experimental Dermatology | 4 Jul 2016 | 36 |
| 47 | TGFβ-signaling in Squamous Cell Carcinoma Occurring in Recessive Dystrophic Epidermolysis Bullosa Julia Knaup, Christina Guttmann‐Gruber, Barbara E. Krammer et al. · Analytical Cellular Pathology | 2011 | 35 |
| 48 | Context-Dependent Strategies for Enhanced Genome Editing of Genodermatoses Oliver Patrick March, Thomas Köcher, Ulrich Koller · Cells | 2 Jan 2020 | 35 |
| 49 | Synergistic effects of dendritic cell targeting and laser-microporation on enhancing epicutaneous skin vaccination efficacy Yoan J. Machado et al. · Journal of Controlled Release | 14 Sep 2017 | 35 |
| 50 | Gene editing for skin diseases: designer nucleases as tools for gene therapy of skin fragility disorders Oliver Patrick March, Julia Reichelt, Ulrich Koller · Experimental Physiology | 8 Mar 2017 | 34 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.